Tryp Therapeutics Appoints Dennis Langer as Senior Advisor to the Company
August 18, 2021 at 10:11 am EDT
Tryp Therapeutics announced the appointment of Dennis Langer, M.D., J.D., as Senior Advisor to the Company. Dr. Langer has been a Director, Co-Founder, and CEO of various public and private biotechnology, specialty pharmaceutical, and diagnostic companies. He previously served as Senior Vice President of Research and Development at GlaxoSmithKline and as CEO of Neose Technologies. He currently serves as a Director of Myriad Genetics Inc. and the Whitehead Institute for Biomedical Research.